[1] |
Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015[J]. CA Cancer J Clin, 2015, 65(6):457-480.
|
[2] |
Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma: current management and perspectives for the future[J]. Ann Surg, 2011, 253(3):453-469.
|
[3] |
Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome[J]. Liver Transpl, 2004, 10(2 Suppl 1):S39-45.
|
[4] |
Llovet JM, Di Bisceglie AM, Bruix J, et a1.Design and endpoints of clinical trials in hepatocellular carcinoma[J].J Natl Cancer Inst, 2008, 100(10):698-711.
|
[5] |
Nishida S, Levi DM, Tz akis AG. Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma[J]. Curr Opin Organ Transplant, 2013, 18(6):690-694.
|
[6] |
Eguchi S, Kanematsu T, Arii S, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey[J]. Surgery, 2008, 143(4):469-475.
|
[7] |
Fan ST. Precise hepatectomy guided by the middle hepatic vein[J]. Hepatobiliary Pancreat Dis Int, 2007, 6(4):430-434.
|
[8] |
董家鸿, 黄志强.精准肝切除——21世纪肝脏外科新理念[J].中华外科杂志,2009,47(21):1601-1605.
|
[9] |
Lee KT, Wang SN, Su RW, et al. Is wider surgical margin justified for better clinical outcomes in patients with resectable hepatocellular carcinoma?[J]. J Formos Med Assoc, 2012, 111(3):160-170.
|
[10] |
Ker CG, Chen HY, Chen HJ, et al. Challenge of safety margin in laparoscopic liver resection for hepatocellular carcinoma[J]. Formos J Surg, 2014, 47(5): 183-188.
|
[11] |
Hu W, Pang X, Guo W, et al. Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2015, 8(3):3404-3409.
|
[12] |
Arnaoutakis DJ, Mavros MN, Shen F, et al. Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis[J]. Ann Surg Oncol, 2014, 21(1): 147-154.
|
[13] |
Wakabayashi H, Ushiyama T, Ishimura K, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions [J]. J Surg Oncol, 2003, 82(2):98-103.
|
[14] |
Yasuda S, Nomi T, Hokuto D, et al. Huge hepatocellular carcinoma with multiple intrahepatic metastases: an aggressive multimodal treatment[J]. Int J Surg Case Rep, 2015(16):44-47.
|
[15] |
Seshadri RM, Baker EH, Templin M, et al. Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database[J]. HPB, 2015, 17(11): 964-968.
|
[16] |
Sugawara Y, Kokudo N. Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation[J]. Oncology, 2008, 75 Suppl 1:119-123.
|
[17] |
Lee HS, Choi GH, Joo DJ, et al. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation[J]. Ann Surg Oncol, 2014, 21(8):2717-2724.
|
[18] |
Kobayashi T, Ishiyama K, Ohdan H. Prevention of recurrence after curative treatment for hepatocellular carcinoma[J]. Surg Today, 2013, 43(12):1347-1354.
|
[19] |
孙建,简志祥,区应亮,等.肝癌根治性切除术后早期复发时限和模式的确定及其对预后的影响[J].实用医学杂志,2011,27(10):1748-1750.
|
[20] |
Zhong JH, Zhong QL, Li LQ, et al. Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review[J]. Tumour Biol, 2014, 35(10):9459-9468.
|
[21] |
Zheng Z, Liang W, Wang D, et al. Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis[J]. Int J Cancer, 2015, 136(6):E751-759.
|
[22] |
Andreou A, Vauthey JN, Cherqui D, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy[J]. J Gastrointest Surg, 2013, 17(1):66-77.
|
[23] |
吕毅,张谞丰.肝细胞肝癌的多学科协作组概念及其实践[J/CD].中华肝脏外科手术学电子杂志,2013,2(1):1-3.
|